Company profile for TNF Pharmaceuticals

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

TNF Pharma is a biotechnology company focused on developing innovative therapeutics targeting TNF (Tumor Necrosis Factor) biology to treat a wide range of inflammatory and autoimmune diseases. By leveraging cutting-edge research and a deep understanding of TNF pathways, we are committed to creating breakthrough treatments that address unmet medical needs and improve patient outcomes. Our mission is to transform the lives of pa...
TNF Pharma is a biotechnology company focused on developing innovative therapeutics targeting TNF (Tumor Necrosis Factor) biology to treat a wide range of inflammatory and autoimmune diseases. By leveraging cutting-edge research and a deep understanding of TNF pathways, we are committed to creating breakthrough treatments that address unmet medical needs and improve patient outcomes. Our mission is to transform the lives of patients through advanced therapies that provide lasting relief from chronic conditions. At TNF Pharma, we strive to lead in innovation and deliver impactful healthcare solutions.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
855 N Wolfe St, Ste 623 Baltimore, Maryland 21205
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.pharmiweb.com/press-release/2025-09-24/tnf-pharmaceuticals-announces-name-change-to-qc-technologies-and-new-ticker-symbol-qcls-to-reflec

PHARMAWEB
24 Sep 2025

https://www.businesswire.com/news/home/20250917806538/en/TNF-Pharmaceuticals-Regains-Compliance-with-Nasdaq-Minimum-Bid-Price-Requirement

BUSINESSWIRE
17 Sep 2025

https://www.pharmiweb.com/press-release/2025-09-04/tnf-pharmaceuticals-announces-closing-of-7-million-private-placement

PHARMAWEB
04 Sep 2025

https://www.pharmiweb.com/press-release/2025-09-02/tnf-pharmaceuticals-secures-exclusive-global-rights-to-innovative-light-speed-computing-accelerator

PHARMAWEB
02 Sep 2025

https://www.businesswire.com/news/home/20250828785479/en/TNF-Pharmaceuticals-Announces-Reverse-Stock-Split-For-Nasdaq-Listing-Compliance

BUSINESSWIRE
28 Aug 2025

https://www.businesswire.com/news/home/20250819482046/en/TNF-Pharmaceuticals-Strengthens-Financial-Position-for-Growth-and-Value-Creation

BUSINESSWIRE
19 Aug 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty